glp 1 for ra GLP-1 Agonists GLP-1 Medications and Rheumatoid Arthritis:

Based on REDEFINE trial populations and the NDA submission terms, expected eligibility criteria are: BMI 30 , or BMI 27 with at least one weight-related condition such as hypertension, dyslipidemia, type 2 diabetes, or obstructive sleep apnea Adults 18 years or older Not pregnant or breastfeeding Contraindications will likely include: personal or family history of MTC or MEN 2 syndrome, prior serious allergic reaction to semaglutide or cagrilintide, and active pancreatitis

Then switch to as needed only

Eisermann K, Fraizer G

For future reconstitutions, angle the needle toward the vial wall and depress the plunger slowly over 1015 seconds to minimize impact forces

This week's Pharmaville editorial covers iBio's approach to that shift

Injections bypass the gastrointestinal tract and are the standard treatment for pernicious anaemia and severe deficiency in the UK